CINECA IRIS Institutional Research Information System

BASOLO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.581
AS - Asia 14.719
EU - Europa 13.401
SA - Sud America 2.494
AF - Africa 757
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 15
Totale 62.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.740
SG - Singapore 4.522
CN - Cina 4.246
IT - Italia 4.061
HK - Hong Kong 2.866
SE - Svezia 2.488
DE - Germania 2.175
BR - Brasile 2.139
BG - Bulgaria 1.100
GB - Regno Unito 895
TR - Turchia 820
VN - Vietnam 778
CA - Canada 651
RU - Federazione Russa 530
FI - Finlandia 489
AT - Austria 449
UA - Ucraina 389
CI - Costa d'Avorio 322
KR - Corea 312
IN - India 307
FR - Francia 212
JP - Giappone 165
SN - Senegal 149
CH - Svizzera 135
BD - Bangladesh 133
AR - Argentina 123
NL - Olanda 114
IQ - Iraq 97
BE - Belgio 86
MX - Messico 69
PK - Pakistan 69
PL - Polonia 60
ID - Indonesia 59
ZA - Sudafrica 57
EC - Ecuador 56
SA - Arabia Saudita 54
MA - Marocco 50
VE - Venezuela 47
NG - Nigeria 46
ES - Italia 45
UZ - Uzbekistan 42
CO - Colombia 41
JO - Giordania 33
LT - Lituania 25
KE - Kenya 24
EG - Egitto 23
IR - Iran 23
PY - Paraguay 23
IL - Israele 21
UY - Uruguay 20
AU - Australia 19
AZ - Azerbaigian 18
PA - Panama 18
PE - Perù 18
RO - Romania 17
BJ - Benin 16
CZ - Repubblica Ceca 16
JM - Giamaica 16
TN - Tunisia 16
DO - Repubblica Dominicana 15
GR - Grecia 15
MY - Malesia 15
NP - Nepal 15
AL - Albania 14
CL - Cile 14
EU - Europa 14
IE - Irlanda 14
TT - Trinidad e Tobago 13
DZ - Algeria 11
PT - Portogallo 11
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
HN - Honduras 10
PH - Filippine 10
RS - Serbia 10
ET - Etiopia 9
HU - Ungheria 9
KZ - Kazakistan 9
LB - Libano 9
OM - Oman 9
PS - Palestinian Territory 9
BO - Bolivia 8
EE - Estonia 8
BY - Bielorussia 7
NI - Nicaragua 7
BH - Bahrain 6
BN - Brunei Darussalam 6
GA - Gabon 6
KG - Kirghizistan 6
AO - Angola 5
BB - Barbados 5
DK - Danimarca 5
LK - Sri Lanka 5
AM - Armenia 4
CY - Cipro 4
GD - Grenada 4
GT - Guatemala 4
KH - Cambogia 4
KW - Kuwait 4
Totale 62.898
Salva come PNG Salva come JPEG
Città #
Ashburn 3.500
Fairfield 3.026
Hong Kong 2.740
Woodbridge 2.475
Singapore 2.394
Dallas 2.179
Chandler 2.174
Houston 1.810
Ann Arbor 1.627
Santa Clara 1.611
Seattle 1.280
Wilmington 1.118
Sofia 1.096
Cambridge 1.007
Shanghai 1.000
Beijing 953
New York 791
Milan 688
Boardman 530
Ottawa 523
Izmir 511
Serra 504
Princeton 485
Lawrence 442
Jacksonville 438
Los Angeles 416
Medford 393
Vienna 393
Hefei 374
Abidjan 321
Nanjing 317
Seoul 296
Des Moines 257
Florence 249
Pisa 243
Munich 227
London 220
Istanbul 203
San Diego 199
Dearborn 189
São Paulo 183
Buffalo 179
Frankfurt am Main 179
Columbus 178
The Dalles 172
Redondo Beach 163
Rome 151
Dakar 149
Dong Ket 147
Council Bluffs 133
Tokyo 131
Ho Chi Minh City 127
Nanchang 120
Bern 115
Bremen 113
Boulder 93
Falls Church 91
Kunming 90
Ogden 90
Hanoi 88
Brussels 81
Turku 79
Chicago 78
Rio de Janeiro 75
Lancaster 69
Shenyang 69
Jüchen 68
Changsha 66
Redwood City 63
Naples 61
Hebei 54
Belo Horizonte 53
Düsseldorf 51
Pune 51
Washington 51
San Jose 48
Bologna 47
Fuzhou 47
Nürnberg 46
Tianjin 46
Norwalk 45
Helsinki 43
Cascina 42
Guangzhou 42
Toronto 42
Jiaxing 41
Warsaw 41
Brasília 40
Lagos 40
Tashkent 40
Baghdad 39
Phoenix 39
San Francisco 39
Hangzhou 37
Jinan 37
Lucca 36
Quanzhou 36
Montreal 35
Nuremberg 35
Zhengzhou 34
Totale 43.877
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.089
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 323
null 259
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 245
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 242
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 241
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 236
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 235
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 233
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 231
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 226
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 224
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 221
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 221
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 219
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 213
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 209
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 209
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 207
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 206
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 206
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 206
Picornavirus-induced immuno-suppression 205
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 205
Molecular testing in the diagnosis of differentiated thyroid carcinomas 204
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 203
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 202
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 201
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 201
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 198
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 196
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 196
A proteomic approach to study parathyroid glands 190
Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report 190
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 189
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 188
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 188
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 187
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 187
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 187
A pandemic recap: lessons we have learned 187
Surgical treatment of pleural recurrence from thymoma 186
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 185
MULTIPLE ORGAN-REACTIVITY OF MONOCLONAL AUTOANTIBODIES TO MOUSE ERYTHROCYTES 183
PRODUCTIVE HIV-1 INFECTION OF NORMAL HUMAN MAMMARY EPITHELIAL-CELLS 182
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 182
DIABETES MELLITUS 179
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes 179
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 178
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 178
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 177
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 177
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 176
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 176
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 176
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 175
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 174
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 174
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 174
SYSTEMIC LYMPHOID ATROPHY IN COXSACKIE-VIRUS B3-INFECTED MICE - EFFECTS OF VIRUS AND IMMUNOPOTENTIATING AGENTS 173
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 172
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 171
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes 171
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 169
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 169
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 169
MATRIGEL PROMOTES RETINOBLASTOMA CELL-GROWTH INVITRO AND INVIVO 168
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 168
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 168
Influence of T and N stages on long term survival in resectable small cell lung cancer 167
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 167
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 167
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 166
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 166
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations 166
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 165
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 165
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 165
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 165
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 165
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 164
Lipomatous hamartoma-like lesion of a bicuspid aortic valve: an incidental surgical finding 164
miR-19a and miR-20a and tissue factor expression in activated human peripheral blood mononuclear cells 164
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 164
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 163
Ectopic expression of bone sialoprotein in human thyroid cancer 162
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 162
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 162
Prevalence of Thyroid Cancer in Multinodular Goiter Versus Single Nodule: Iodine Intake and Cancer Phenotypes. 162
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 162
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 162
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 161
ADJUVANT CHEMOTHERAPY FOR T1-2NOMO SMALL-CELL LUNG-CANCER - SINGLE-AGENT OR COMBINATION CHEMOTHERAPY 160
null 160
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 160
GENETIC MARKERS TO DISCRIMINATE BENIGN AND MALIGNANT THYROID NODULES WITH UNDETERMINED CYTOLOGY IN AN AREA OF BORDERLINE IODINE DEFICIENCY. 160
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 160
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 159
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 159
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 159
Totale 19.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.312 0 0 0 0 0 189 290 386 352 317 231 547
2021/20225.354 124 221 151 396 993 829 161 236 281 264 292 1.406
2022/20237.091 891 958 515 641 755 887 100 573 1.194 64 434 79
2023/20244.454 476 416 481 358 635 836 190 155 145 116 174 472
2024/202515.020 124 571 152 900 1.449 1.492 1.212 853 1.581 1.878 1.584 3.224
2025/20269.597 1.081 2.203 2.215 1.404 1.471 1.223 0 0 0 0 0 0
Totale 63.884